FBXL15
Basic information
Region (hg38): 10:102419189-102423136
Previous symbols: [ "FBXO37" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FBXL15 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 13 | 13 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 13 | 0 | 0 |
Variants in FBXL15
This is a list of pathogenic ClinVar variants found in the FBXL15 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
10-102421139-C-G | not specified | Uncertain significance (May 09, 2022) | ||
10-102421160-G-A | not specified | Uncertain significance (Oct 12, 2024) | ||
10-102421168-G-T | not specified | Uncertain significance (Mar 07, 2024) | ||
10-102421449-C-A | not specified | Uncertain significance (Nov 25, 2024) | ||
10-102421467-A-T | not specified | Uncertain significance (Feb 20, 2025) | ||
10-102421914-G-A | not specified | Uncertain significance (May 16, 2024) | ||
10-102421946-G-A | not specified | Uncertain significance (Oct 05, 2023) | ||
10-102421964-C-G | not specified | Uncertain significance (Nov 10, 2024) | ||
10-102422042-G-T | not specified | Uncertain significance (Mar 29, 2022) | ||
10-102422058-G-A | not specified | Uncertain significance (Dec 09, 2024) | ||
10-102422159-G-T | not specified | Uncertain significance (Dec 14, 2024) | ||
10-102422169-G-C | not specified | Uncertain significance (Nov 14, 2024) | ||
10-102422244-A-G | not specified | Uncertain significance (Oct 26, 2021) | ||
10-102422836-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
10-102422865-G-T | not specified | Uncertain significance (Nov 02, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
FBXL15 | protein_coding | protein_coding | ENST00000224862 | 4 | 3948 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0143 | 0.881 | 123953 | 0 | 7 | 123960 | 0.0000282 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.67 | 98 | 157 | 0.624 | 0.00000727 | 1824 |
Missense in Polyphen | 30 | 55.982 | 0.53589 | 730 | ||
Synonymous | -0.209 | 80 | 77.7 | 1.03 | 0.00000371 | 678 |
Loss of Function | 1.35 | 4 | 8.18 | 0.489 | 3.49e-7 | 99 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000694 | 0.0000633 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000115 | 0.000109 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000296 | 0.0000269 |
Middle Eastern | 0.000115 | 0.000109 |
South Asian | 0.0000333 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Substrate recognition component of a SCF (SKP1-CUL1-F- box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of SMURF1, thereby acting as a positive regulator of the BMP signaling pathway. Required for dorsal/ventral pattern formation and bone mass maintenance. Also mediates ubiquitination of SMURF2 and WWP2. {ECO:0000269|PubMed:21572392}.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.105
Haploinsufficiency Scores
- pHI
- 0.205
- hipred
- Y
- hipred_score
- 0.716
- ghis
- 0.432
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.579
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Fbxl15
- Phenotype
Zebrafish Information Network
- Gene name
- fbxl15
- Affected structure
- trunk
- Phenotype tag
- abnormal
- Phenotype quality
- increased curvature
Gene ontology
- Biological process
- G2/M transition of mitotic cell cycle;protein polyubiquitination;ubiquitin-dependent protein catabolic process;dorsal/ventral pattern formation;protein ubiquitination;bone mineralization;positive regulation of BMP signaling pathway;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification
- Cellular component
- cytoplasm;cytosol;SCF ubiquitin ligase complex
- Molecular function
- ubiquitin-protein transferase activity;protein binding